centered image

dupilumab

  1. Mahmoud Abudeif
    Thread

    FDA OKs Dupilumab for Moderate-to-Severe Eczema in Teens

    [IMG] The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent, Sanofi/Regeneron) for adolescents aged 12 to 17 years with...
    Thread by: Mahmoud Abudeif, Mar 23, 2019, 0 replies, in forum: Dermatology
Showing results 1 to 1 of 1
<